DarioHealth Statistics
Total Valuation
DarioHealth has a market cap or net worth of $25.90 million. The enterprise value is $27.63 million.
Important Dates
The last earnings date was Monday, March 10, 2025, before market open.
| Earnings Date | Mar 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DarioHealth has 41.57 million shares outstanding. The number of shares has increased by 72.85% in one year.
| Current Share Class | 41.57M |
| Shares Outstanding | 41.57M |
| Shares Change (YoY) | +72.85% |
| Shares Change (QoQ) | +95.16% |
| Owned by Insiders (%) | 12.55% |
| Owned by Institutions (%) | 21.87% |
| Float | 33.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.13 |
| Forward PS | 1.35 |
| PB Ratio | 0.33 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.44 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -65.68% and return on invested capital (ROIC) is -37.53%.
| Return on Equity (ROE) | -65.68% |
| Return on Assets (ROA) | -33.11% |
| Return on Invested Capital (ROIC) | -37.53% |
| Return on Capital Employed (ROCE) | -55.76% |
| Revenue Per Employee | $133,861 |
| Profits Per Employee | -$148,955 |
| Employee Count | 202 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 1.78 |
Taxes
| Income Tax | -1.85M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.01% in the last 52 weeks. The beta is 1.42, so DarioHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -59.01% |
| 50-Day Moving Average | 0.67 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 41.41 |
| Average Volume (20 Days) | 283,330 |
Short Selling Information
The latest short interest is 2.80 million, so 6.74% of the outstanding shares have been sold short.
| Short Interest | 2.80M |
| Short Previous Month | 2.71M |
| Short % of Shares Out | 6.74% |
| Short % of Float | 8.34% |
| Short Ratio (days to cover) | 7.88 |
Income Statement
In the last 12 months, DarioHealth had revenue of $27.04 million and -$30.09 million in losses. Loss per share was -$0.61.
| Revenue | 27.04M |
| Gross Profit | 18.30M |
| Operating Income | -57.02M |
| Pretax Income | -52.73M |
| Net Income | -30.09M |
| EBITDA | -49.59M |
| EBIT | -57.02M |
| Loss Per Share | -$0.61 |
Full Income StatementBalance Sheet
The company has $28.46 million in cash and $30.19 million in debt, giving a net cash position of -$1.73 million or -$0.04 per share.
| Cash & Cash Equivalents | 28.46M |
| Total Debt | 30.19M |
| Net Cash | -1.73M |
| Net Cash Per Share | -$0.04 |
| Equity (Book Value) | 72.02M |
| Book Value Per Share | 1.88 |
| Working Capital | 23.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$38.56 million and capital expenditures -$138,000, giving a free cash flow of -$38.70 million.
| Operating Cash Flow | -38.56M |
| Capital Expenditures | -138,000 |
| Free Cash Flow | -38.70M |
| FCF Per Share | -$0.93 |
Full Cash Flow StatementMargins
Gross margin is 67.66%, with operating and profit margins of -210.85% and -158.09%.
| Gross Margin | 67.66% |
| Operating Margin | -210.85% |
| Pretax Margin | -164.94% |
| Profit Margin | -158.09% |
| EBITDA Margin | -183.39% |
| EBIT Margin | -210.85% |
| FCF Margin | n/a |
Dividends & Yields
DarioHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -72.85% |
| Shareholder Yield | -72.85% |
| Earnings Yield | -116.19% |
| FCF Yield | -149.44% |
Analyst Forecast
The average price target for DarioHealth is $2.00, which is 221.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.00 |
| Price Target Difference | 221.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | -45.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on November 18, 2019. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Nov 18, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
DarioHealth has an Altman Z-Score of -5.22 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.22 |
| Piotroski F-Score | 3 |